Last reviewed · How we verify

NCT04486235

A Randomized, Controlled Pilot Study of a Patient-Initiated Approach to Increasing Weight Communication in Primary Care

Completed NA Results posted Last updated 6 May 2021
What this trial tests

NA trial testing Brief waiting room pamphlet in Obesity in 62 participants. Completed in 1 November 2020.

Timeline
9 April 2019
Primary endpoint
1 September 2020
1 November 2020

Quick facts

Lead sponsorDrexel University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposeother
Enrollment62
Start date9 April 2019
Primary completion1 September 2020
Estimated completion1 November 2020
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

Drexel University

Who can join

18 and older, any sex, with Obesity or Primary Care. Patients with the condition only — healthy volunteers not accepted.

Results — posted to ClinicalTrials.gov

Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.

Treatment Acceptability Questionnaire Primary · Immediately after appointment (Same day as intervention delivery)

Intervention participants reported acceptability, as measured by the Treatment Acceptability Questionnaire (Hunsley, 1992). This is a 6-item scale that asks the participant to rate several metrics of acceptability with Likert scale responses (individual items range 1-7, one item is reverse scored). A higher score indicates greater acceptability, a score of 21 is the benchmark for acceptability. Overall range of 6-42.

GroupValue95% CI
Intervention35.8± 5.5
Feasibility of Recruitment From Primary Care Waiting Room and Intervention Delivery Primary · When study staff is recruiting in the office during the data collection period, approx. 20 days over 6 months

Study flow will be tracked by study staff and compared to pre-determined benchmarks. 1) Percentage of patients who indicate verbal consent for screening (benchmark \>70%), 2) percentage of eligible participants after screening (benchmark \>50%), 3) percentage of participants who refuse to participate because of focus on weight (benchmark \<20%), 4)percentage of participants who complete the experiential pamphlet (benchmark \>80%).

Percentage of participants indicated verbal consent for screening
GroupValue95% CI
Feasibility, Tracked by Participant Flow60
Percentage of eligible participants after screening
GroupValue95% CI
Feasibility, Tracked by Participant Flow53.5
Percentage of screened participants who refuse to participate because of focus on weight
GroupValue95% CI
Feasibility, Tracked by Participant Flow0
Percentage of participants who complete the experiential pamphlet
GroupValue95% CI
Feasibility, Tracked by Participant Flow86.2
If Weight Was Spoken About in the Appointment Secondary · Immediately after appointment (Same day as intervention delivery)

Participants respond to Yes/No questions about content of their appointment

Patient-initiated weight discussion occured
GroupValue95% CI
Intervention7
Control5
Patient- or physician-initiated weight discussion occurred
GroupValue95% CI
Intervention14
Control11

Sponsor's own description

This study tests the feasibility, acceptability, and preliminary efficacy of using a brief pamphlet in the primary care waiting room focused on promoting patient-initiated weight-related discussions in primary care appointments.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Obesity

Currently open trials in the same condition.

Other Drexel University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04486235.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing